Navigation Links
Cooling treatment after cardiac arrest is cost-effective, Penn study shows

(PHILADELPHIA) A brain-preserving cooling treatment called therapeutic hypothermia is a cost-effective way to improve outcomes after out-of-hospital cardiac arrest, which claims the lives of more than 300,000 people each year in the United States and leaves thousands of others neurologically devastated. The treatment, which lowers body temperature to prevent damage to the brain and other major organs when blood flow is restored to the body following cardiac arrest, is considered a good value when compared to many other accepted and widely utilized medical treatments, including dialysis for kidney failure or complex heart surgeries, according to new University of Pennsylvania School of Medicine research published this week in Circulation: Cardiovascular Quality and Outcomes.

"Having already established that hypothermia improves neurological outcomes after cardiac arrest, we now know that the therapy is also a good use of health care resources," says lead author Raina M. Merchant, MD, MS, an emergency physician and Robert Wood Johnson Clinical Scholar at Penn Medicine. "We hope our findings will help more hospitals and insurers to adopt cooling protocols and help more survivors return to productive lives."

Despite national recommendations established in 2005 calling for out-of-hospital cardiac arrest patients to be treated with hypothermia when they remain comatose after resuscitation, many hospitals still don't offer the intervention. Among barriers to its use: Concerns about its cost, and difficulty coordinating the interdisciplinary resources and staff needed to employ the treatment. Merchant and her colleagues used a complex mathematical design to measure quality-adjusted survival after cardiac arrest, cost of hypothermia equipment and treatment, and cost of post-hospital discharge care. Factors affecting costs included additional nursing care required during cooling treatment, extra time spent in the intensive care unit and post-discharge care required. They found that hypothermia has a cost of less than $100,000 per quality-adjusted life year (QALY), a measurement designed to illustrate the gains in both extra years of life and quality of life from a particular treatment.

Previous research has shown that about six out-of-hospital cardiac arrest patients need to be treated with hypothermia in order for one additional patient to be discharged without the brain damage that characterizes many survivors. Even when the authors of the new study adjusted their model to increase the proportion of neurologically impaired survivors in the group who received hypothermia, results still showed favorable cost-effectiveness estimates for hypothermia.

The findings also revealed that hypothermia treatment is actually less expensive than other interventions that have been implemented to treat cardiac arrest across the United States, including widespread CPR and defibrillation training for the public. In addition, the new research is among few studies to examine the costs of caring for patients who survive cardiac arrest with neurological deficits a tremendous burden for the health care system and family caregivers.

"There are very few treatments for cardiac arrest victims, and hypothermia stands out as the only therapy which can improve neurologic survival," Merchant says. "Hospitals and physicians should promote rapid adoption of this treatment for patients, and cost should not be considered a barrier to use."


Contact: Holly Auer
University of Pennsylvania School of Medicine

Related medicine news :

1. Novel Cooling Therapy May Have Aided Injured Football Player
2. Skin Cooling After Laser Treatment Could Leave Marks
3. Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStors Green Clustered NAS Solution
4. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
5. Cooling May Not Help Injured Brains in Children
6. Late-breaking results of clinical trial on therapeutic endovascular cooling reported at TCT 2008
7. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
8. BeneChill Launches European Study of Intra-Arrest Cooling
9. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
10. St. Josephs Healthcare System Becomes First Hospital in the Region to Implement Pre-Hospital Therapeutic Cooling to Save the Lives of Cardiac Arrest Patients
11. Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... is encouraging people across the country to celebrate their sobriety and show through ... to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... physicians and athletic programs, launches new Wimbledon Athletics Facebook page to ... young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age of ...
(Date:11/25/2015)... ... 2015 , ... Smiles by Stevens is pleased to announce the ... While many patients are aware of the benefits of Botox® in the treatment of ... suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s ... learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions ... 65 years, Brillianteen has been a treasured tradition for numerous families in the ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: